BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 7828132)

  • 1. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
    Kwong YL; Chan V; Wong KF; Chan TK
    Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
    Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
    Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
    Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
    Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
    Jurlander J; Caligiuri MA; Ruutu T; Baer MR; Strout MP; Oberkircher AR; Hoffmann L; Ball ED; Frei-Lahr DA; Christiansen NP; Block AM; Knuutila S; Herzig GP; Bloomfield CD
    Blood; 1996 Sep; 88(6):2183-91. PubMed ID: 8822938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.
    Viehmann S; Teigler-Schlegel A; Bruch J; Langebrake C; Reinhardt D; Harbott J
    Leukemia; 2003 Jun; 17(6):1130-6. PubMed ID: 12764380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
    Nucifora G; Rowley JD
    Leuk Lymphoma; 1994 Aug; 14(5-6):353-62. PubMed ID: 7812194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay.
    Marcucci G; Livak KJ; Bi W; Strout MP; Bloomfield CD; Caligiuri MA
    Leukemia; 1998 Sep; 12(9):1482-9. PubMed ID: 9737700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.
    Tsukamoto N; Karasawa M; Tanaka Y; Yokohama A; Uchiumi H; Matsushima T; Murakami H; Nojima Y
    Int J Hematol; 2003 Nov; 78(4):362-9. PubMed ID: 14686496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
    de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
    Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes.
    Barragán E; Bolufer P; Moreno I; Martín G; Nomdedeu J; Brunet S; Fernández P; Rivas C; Sanz MA
    Leuk Lymphoma; 2001 Aug; 42(4):747-56. PubMed ID: 11697505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission.
    Guerrasio A; Rosso C; Martinelli G; Lo Coco F; Pampinella M; Santoro A; Lanza C; Allione B; Resegotti L; Saglio G
    Br J Haematol; 1995 Jun; 90(2):364-8. PubMed ID: 7794758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia.
    Maruyama F; Stass SA; Estey EH; Cork A; Hirano M; Ino T; Freireich EJ; Yang P; Chang KS
    Leukemia; 1994 Jan; 8(1):40-5. PubMed ID: 7507193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia.
    van de Locht LT; Smetsers TF; Wittebol S; Raymakers RA; Mensink EJ
    Leukemia; 1994 Oct; 8(10):1780-4. PubMed ID: 7523801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
    Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
    Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells.
    Era T; Asou N; Kunisada T; Yamasaki H; Asou H; Kamada N; Nishikawa S; Yamaguchi K; Takatsuki K
    Genes Chromosomes Cancer; 1995 May; 13(1):25-33. PubMed ID: 7541640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
    Zhang Y; Strissel P; Strick R; Chen J; Nucifora G; Le Beau MM; Larson RA; Rowley JD
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3070-5. PubMed ID: 11867721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
    Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
    Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22).
    Zhang L; Li Q; Li W; Liu B; Wang Y; Lin D; Zhou C; Li C; Wang J; Mi Y
    Int J Hematol; 2013 Jun; 97(6):786-92. PubMed ID: 23613269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia.
    Miyamoto T; Nagafuji K; Harada M; Eto T; Fujisaki T; Kubota A; Akashi K; Mizuno S; Takenaka K; Kanaji T
    Br J Haematol; 1995 Sep; 91(1):132-8. PubMed ID: 7577620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8; 21).
    Tobal K; Yin JA
    Blood; 1996 Nov; 88(10):3704-9. PubMed ID: 8916934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.